These medications slow gastric emptying and suppress appetite, which may reduce oral intake while increasing losses of sodium, potassium, magnesium, and other essential minerals
Muscle pain and body aches sometimes appear, especially at higher doses
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education
Licensing trials for Semaglutide (the active ingredient in Ozempic) showed better results than later real-world trials
Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: a randomized, placebo-controlled, crossover study
Starting Ozempic, Wegovy, Mounjaro, Zepbound, or another GLP-1 medication changes how your body handles food but most patients are never told exactly which foods will now cause problems